New stock news | English Pharmaceuticals Hong Kong IPO and domestic unlisted shares "fully circulated" have been filed by the China Securities Regulatory Commission

date
16:40 30/03/2026
avatar
GMT Eight
On March 30, the International Cooperation Department of the China Securities Regulatory Commission issued the "Notice on the Overseas Issuance and Listing of Nanjing Yingpai Pharmaceuticals Co., Ltd. and the Filing of the 'Full Circulation' of Unlisted Shares Domestically".
On March 30th, the International Cooperation Department of the China Securities Regulatory Commission issued a "Notice of Filing for Overseas Issuance and Listing of Nanjing Yingpai Pharmaceutical Co., Ltd. and Full Circulation of Unlisted Domestic Shares" Yingpai Pharmaceutical plans to issue no more than 89,771,800 shares of overseas listed common stock and list them on the Hong Kong Stock Exchange. A total of 43 shareholders of the company plan to convert their combined 234,188,130 shares of unlisted domestic shares to overseas listed shares and list them for circulation on the Hong Kong Stock Exchange. The names and conversion quantities of the "full circulation" shareholders are as follows: